Russia plans to increase public procurements of anti-cancer drugs that will be part of a new national project, which aims to ...
Danish pharma major Novo Nordisk today announced the top-line results from HIBISCUS, a pivotal Phase III trial of once-daily ...
US clinical-stage biotech Neurogene today announced the appointment of Christy Shafer as chief commercial officer and the appointment of Christine Mikail to its board of directors.
The US Food and Drug Administration (FDA) is ramping up government efforts to curb misinformation on prescription drugs that ...
AstraZeneca today announced results from its third positive pivotal Phase III MIRANDA trial studying potential first-in-class ...
Cambridge, UK-based biotech Bicycle Therapeutics, a pharmaceutical company pioneering a new and differentiated class of ...
French pharma major Sanofi's protein-based non-mRNA COVID-19 vaccine Nuvaxovid (NVX-CoV2705) demonstrated ...
The Association of Pharmaceutical Enterprises of Greece (SFEE) announced the launch of the new strategic initiative ...
Regulators in the USA, Europe and Asia used the past week to push through a mix of technical guidance, supply interventions ...
US clinical-stage biopharma company Nuvalent on Friday announced new clinical and pre-clinical data for zidesamtinib, an ...
Israeli-US drugmaker Teva has regained the upper hand in its long-running migraine patent dispute with US pharma major Eli ...
Japan’s Nxera Pharma (TYO: 4565) announces that it has reached a third R&D milestone under its multi-target discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results